JANEY HARDESTY: Open Payments
NPI 1881194751 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 63 payments from 15 companies in 2025. Trend: 2023 $1,189 · 2024 $1,536 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 7 | $307 |
| PFIZER INC. | 18 | $190 |
| Merck Sharp & Dohme LLC | 6 | $114 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $97 |
| Novartis Pharmaceuticals Corporation | 6 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| SCPHARMACEUTICALS INC. | 2 | $58 |
| Abbott Laboratories | 2 | $56 |
| BridgeBio Pharma, Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
Products named: ONPATTRO, AMVUTTRA, ELIQUIS, VYNDAQEL, LifeVest, LEQVIO, VERQUVO, FUROSCIX.
Industry payments across IN — which companies pay providers there.
